Monocytes and macrophages in cancer immunotherapy

This publication has 9 references indexed in Scilit:

• Gene therapy researcher under fire over controversial cancer trials
  Nature, 1992
• A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
  The Journal of Experimental Medicine, 1992
• Adoptive Immunotherapy with Activated Macrophages Grown In Vitro from Blood Monocytes in Cancer Patients
  Journal of Immunotherapy, 1992
• Adoptive immunotherapy with bispecific antibodies: targeting through macrophages
  Research in Immunology, 1992
• Tumour-cytolytic human monocyte-derived macrophages: a simple and efficient method for the generation and long-term cultivation as non-adherent cells in a serum-free medium
  Research in Immunology, 1992
• Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: Toxicity and immunomodulatory effects
  Cancer Immunology, Immunotherapy, 1991
• Surface Phenotype Analysis of Human Monocyte to Macrophage Maturation
  Journal of Leukocyte Biology, 1990
• Control of the antitumoral activity of human macrophages produced in large amounts in view of adoptive transfer
  European Journal of Cancer and Clinical Oncology, 1988
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987